CompaniesByCap
ERNA
Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare

Eterna Therapeutics Inc. Income Statement 2010–2024

Income StatementBalance SheetCash Flow
Dec 2024Dec 2023Dec 2022Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
Revenues
Revenue582,00068,00005.8M19.8M23.3M21.3M22.3M24.5M26.0M23.7M24.1M23.9M25.3M
Gross Profit486,000-168,0000
Profitability
Operating Income-15.7M-21.1M-33.2M-7.2M-1.8M203,000-1.4M-2.3M-6.9M-4.7M-1.1M-1.1M-3.3M-325,000
EBITDA-15.5M-21.1M-33.1M-7.2M1.1M3.0M915,000609,000-3.8M-2.0M1.7M1.8M-16,0002.9M
Net Income-44.5M-21.7M-24.6M-7.3M-2.0M-259,000-1.1M-2.9M-7.2M-5.0M-1.1M-995,000-3.4M-400,000
Per Share Data
EPS (diluted)$-48.96$-4.08$-8.06$-0.41
Shares Outstanding (dil.)1M5M3M18M3M3M3M2M2M92M79M71M0M0M

Eterna Therapeutics Inc. Income Statement — FAQ

Eterna Therapeutics Inc. (ERNA) income statement over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ERNA's income statement history?

The chart and table above show Eterna Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.